Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers

作者: Snjezana Dogan , Ronglai Shen , Daphne C. Ang , Melissa L. Johnson , Sandra P. D'Angelo

DOI: 10.1158/1078-0432.CCR-11-3265

关键词:

摘要: Purpose: The molecular epidemiology of most EGFR and KRAS mutations in lung cancer remains unclear. Experimental Design: We genotyped 3,026 adenocarcinomas for the major (exon 19 deletions L858R) (G12, G13) examined correlations with demographic, clinical, smoking history data. Results: were found 43% never smokers 11% smokers. occurred 34% 6% In patients histories up to 10 pack-years, predominated over . Among former cancer, multivariate analysis showed that, independent increasing smoking-free years raise likelihood mutation. Never more likely than have G > A transition mutation (mostly G12D; 58% vs. 20%, P = 0.0001). G12C, common T transversion smokers, was frequent women ( 0.007) these younger men same (median 65 69, 0.0008) had smoked less. Conclusions: distinct types versus suggest that -mutant cancers are not due second-hand smoke exposure. higher frequency G12C women, their age, lesser together support a heightened susceptibility tobacco carcinogens. Clin Cancer Res; 18(22); 6169–77. ©2012 AACR

参考文章(49)
Xue-Ning Yang, Jian Su, Chong-Rui Xu, Yu-Juan Huang, Jin-Ji Yang, Xu-Chao Zhang, Yi-Sheng Huang, Yi-Long Wu, Zhen Wang, Qing Zhou, Impact of smoking status and pathologic type on epidermal growth factor receptor mutations in lung cancer. Chinese Medical Journal. ,vol. 124, pp. 2457- ,(2011)
Gregory J. Riely, Jamie E. Chaft, Marc Ladanyi, Mark G. Kris, Incorporation of crizotinib into the NCCN guidelines Journal of The National Comprehensive Cancer Network. ,vol. 9, pp. 1328- 1330 ,(2011) , 10.6004/JNCCN.2011.0113
Stephen L. Graziano, Gary P. Gamble, Nancy B. Newman, Lynn Z. Abbott, Michelle Rooney, Sulagna Mookherjee, Melissa L. Lamb, Leslie J. Kohman, Bernard J. Poiesz, Prognostic Significance of K-ras Codon 12 Mutations in Patients With Resected Stage I and II Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 17, pp. 668- 668 ,(1999) , 10.1200/JCO.1999.17.2.668
Steven A. Ahrendt, P. Anthony Decker, Enas A. Alawi, Yong-ran Zhu, Montserrat Sanchez-Cespedes, Stephen C. Yang, George B. Haasler, André Kajdacsy-Balla, Michael J. Demeure, David Sidransky, Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Cancer. ,vol. 92, pp. 1525- 1530 ,(2001) , 10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H
Keitaro Matsuo, Hidemi Ito, Yasushi Yatabe, Akio Hiraki, Kaoru Hirose, Kenji Wakai, Takayuki Kosaka, Takeshi Suzuki, Kazuo Tajima, Tetsuya Mitsudomi, Risk factors differ for non-small-cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case-control study in Japanese Cancer Science. ,vol. 98, pp. 96- 101 ,(2007) , 10.1111/J.1349-7006.2006.00347.X
Qiulu Pan, William Pao, Marc Ladanyi, Rapid Polymerase Chain Reaction-Based Detection of Epidermal Growth Factor Receptor Gene Mutations in Lung Adenocarcinomas The Journal of Molecular Diagnostics. ,vol. 7, pp. 396- 403 ,(2005) , 10.1016/S1525-1578(10)60569-7
Shanrong Li, Zdenek Skacel, José Gómez-Codina, Carlos Camps, Mariano Monzó, Josep M. de Anta, Rafael Rosell, Francisco Molina, Isabel Moreno, Eva Martínez, Alex Pifarré, Albert Font, Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in stage IIIA non-small cell lung cancer. Lung Cancer. ,vol. 12, ,(1995) , 10.1016/0169-5002(95)00421-V
Fiamma Buttitta, Fabio Barassi, Giuseppina Fresu, Lara Felicioni, Antonio Chella, Diego Paolizzi, Giuseppe Lattanzio, Simona Salvatore, Pier P. Camplese, Sandra Rosini, Teodorico Iarussi, Felice Mucilli, Rocco Sacco, Andrea Mezzetti, Antonio Marchetti, Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features. International Journal of Cancer. ,vol. 119, pp. 2586- 2591 ,(2006) , 10.1002/IJC.22143
E Santos, D Martin-Zanca, E. Reddy, M. Pierotti, G Della Porta, M Barbacid, Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient Science. ,vol. 223, pp. 661- 664 ,(1984) , 10.1126/SCIENCE.6695174